Clinical Trial Update: Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a fixed-dose combination of Fluoxetin and Metformin for overweight and obesity has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Fluoxetin (Fluoxetin)
• metformin (metformin)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Overweight and Obesity | Phase 2 | Status: SUSPENDED